Current diagnosis of histoplasmosis

Trends in Microbiology

Volumn 11, Issue 10, 2003, Pages 488-494

  Wheat, L Joseph ^a  

^a MIRAVISTA DIAGNOSTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ANTIGEN DETECTION; BLOOD LEVEL; CLINICAL FEATURE; CROSS REACTION; DIAGNOSTIC ACCURACY; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HISTOPATHOLOGY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; LABORATORY DIAGNOSIS; MYCOLOGY; NONHUMAN; PRIORITY JOURNAL; RELAPSE; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; SKIN TEST; URINE LEVEL;

AJELLOMYCES; AJELLOMYCES CAPSULATUS; FUNGI;

EID: 0141483211     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2003.08.007     Document Type: Review

References (51)

1. Wheat L. Histoplasmosis in the acquired immunodeficiency syndrome. Curr. Top. Med. Mycol. 7:1996;7-18.
2. Sathapatayavongs B., et al. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore). 62:1983;263-270.
3. Wheat J., et al. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am. J. Med. 98:1995;336-342.
4. Wheat J., et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. Am. J. Med. 103:1997;223-232.
5. Wheat L.J., et al. Cavitary histoplasmosis occurring during two large urban outbreaks: analysis of clinical, epidemiologic, roentgenograghic, and laboratory features. Medicine (Baltimore). 63:1984;201-209.
6. Stockman L., et al. Evalutation of commericially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J. Clin. Microbiol. 31:1993;845-850.
7. Hutton J.P., et al. Hyphal forms of Histoplasma capsulatum: a common manifestation of intravascular infections. Arch. Pathol. Lab. Med. 109:1985;330-332.
8. Wheat L.J., et al. The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak. Ann. Intern. Med. 97:1982;680-685.
9. Williams B., et al. Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis. Ind. Arch. Pathol. Lab. Med. 118:1994;1205-1208.
10. Wheat L.J., et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore). 69:1990;361-374.
11. Wheat L.J., et al. Evaluation of cross-reactions in Histoplasma capsulatum serologic tests. J. Clin. Microbiol. 23:1986;493-499.
12. Larrabee W.F., et al. An epidemic of histoplasmosis on the isthmus of Panama. Am. J. Trop. Med. Hyg. 27:1978;281-285.
13. Davies S.F. Serodiagnosis of histoplasmosis. Semin. Respir. Infect. 1:1986;9-15.
14. Loosli C.G., et al. Some epidemiological and clinical aspects of pulmonary histoplasmosis in a farm family. Trans. Assoc. Am. Physicians. LXV:1952;159-167.
15. Wheat L.J., et al. Immunoglobulin m and g histoplasmal antibody response in histoplasmosis. Am. Rev. Respir. Dis. 128:1983;65-70.
16. Wheat L.J., et al. Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory. Diagn. Microbiol. Infect. Dis. 43:2002;29-37.
17. Wheat L.J., et al. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N. Engl. J. Med. 314:1986;83-88.
18. Wheat L.J., et al. Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS. Antimicrob. Agents Chemother. 46:2002;248-250.
19. Wheat L.J., et al. Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole. Antimicrob. Agents Chemother. 45:2001;2354-2357.
20. Wheat L.J., et al. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Am. J. Med. 92:1992;153-160.
21. Wheat L.J., et al. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann. Intern. Med. 115:1991;936-941.
22. Johnson J., et al. Cave-associated histoplasmosis: Costa Rica. MMWR Morb. Mortal. Wkly. Rep. 37:1988;312-313.
23. Wheat L.J., et al. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. Am. Rev. Respir. Dis. 145:1992;1421-1424.
24. Kohler S., et al. Clearance of Histoplasma capsulatum variety capsulatum antigen is useful for monitoring treatment of experimental histoplasmosis. J. Clin. Lab. Anal. 8:1994;1-3.
25. Williams B.J., et al. Correlation of Histoplasma capsulatum polysaccharide antigen with the severity of infection in murine histoplasmosis. J. Clin. Lab. Anal. 5:1991;121-126.
26. Connolly P., et al. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice. Antimicrob. Agents Chemother. 43:1999;322-328.
27. Connolly P., et al. Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob. Agents Chemother. 44:2000;2604-2608.
28. Hecht F.M., et al. Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16:1997;100-107.
29. Norris S., et al. Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome. Am. J. Med. 96:1994;504-508.
30. Wheat J., et al. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 118:1993;610-616.
31. Wheat J., et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin. Infect. Dis. 24:1997;1169-1171.
32. Kricka L.J. Human anti-animal antibody interferences in immunological assays. Clin. Chem. 45:1999;942-956.
33. Bialek R., et al. Evaluation of two nested PCR assays for detection of Histoplasma capsulatum DNA in human tissue. J. Clin. Microbiol. 40:2002;1644-1647.
34. Rickerts V., et al. Rapid PCR-based diagnosis of disseminated histoplasmosis in an AIDS patient. Eur. J. Clin. Microbiol. Infect. Dis. 21:2002;821-823.
35. Martagon-Villamil J., et al. Identification of Histoplasma capsulatum from culture extracts by real-time PCR. J. Clin. Microbiol. 41:2003;1295-1298.
36. Wheat L.J., et al. Significance of Histoplasma antigen in the cerebrospinal fluid of patients with meningitis. Arch. Intern. Med. 149:1989;302-304.
37. Wheat L.J., et al. Cerebrospinal fluid Histoplasma antibodies in central nervous system histoplasmosis. Arch. Intern. Med. 145:1985;1237-1240.
38. Wheat L.J., et al. Histoplasma capsulatum infections of the central nervous system: a clinical review. Medicine (Baltimore). 69:1990;244-260.
39. Bialek R., et al. Diagnosis and monitoring of murine histoplasmosis by a nested PCR assay. J. Clin. Microbiol. 39:2001;1506-1509.
40. Collins M.H., et al. Hepatic granulomas in children: a clinicopathologic analysis of 23 cases including polymerase chain reaction for histoplasma. Am. J. Surg. Pathol. 20:1996;332-338.
41. Emmons C.W. Isolation of Histoplasma capsulatum from soil. Am. J. Public Health. 64:1949;892-896.
42. Reid T.M., Schafer M.P. Direct detection of Histoplasma capsulatum in soil suspensions by two-stage PCR. Mol. Cell. Probes. 13:1999;269-273.
43. Chemaly R.F., et al. Rapid diagnosis of Histoplasma capsulatum endocarditis using the AccuProbe on an excised valve. J. Clin. Microbiol. 39:2001;2640-2641.
44. Zeidberg L.D., et al. Some factors in the epidemiology of histoplasmin sensitivity in Williamson County, Tennessee. Am. J. Public Health. 41:1951;80-89.
45. Kaufman L., et al. Effects of a single histoplasmin skin test on the serological diagnosis of histoplasmosis. J. Bacteriol. 94:1967;798-803.
46. Chaparas S.D., et al. Correlation of human skin reactivity with lymphocyte transformation induced by mycobacterial antigens and histoplasmin. Am. Rev. Respir. Dis. 101:1970;67-73.
47. Vail G.M., et al. Cellular immune response in HIV-infected patients with histoplasmosis. J. Acquir. Immune Defic. Syndr. 29:2002;49-53.
48. Mashburn J.D., et al. Pulmonary calcifications and histoplasmosis. Am. Rev. Respir. Dis. 84:1961;208-216.
49. Rubin H., et al. The course and prognosis of histoplasmosis. Am. J. Med. 27:1959;278-288.
50. Loyd J.E., et al. Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore). 67:1988;295-310.
51. Johnson P.C., et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann. Intern. Med. 137:2002;105-109.